BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer.

BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer.

Lack of reliable predictive biomarkers is a stumbling block in the management of prostate cancer (CaP). Prostate-specific antigen (PSA) widely used in clinics has several caveats as a CaP biomarker. African-American CaP patients have poor prognosis than Caucasians, and notably the serum-PSA does not...

Full description

Bibliographic Details
Main Authors: Hifzur Rahman Siddique, Aijaz Parray, Weixiong Zhong, R Jeffery Karnes, Eric J Bergstralh, Shahriar Koochekpour, Johng S Rhim, Badrinath R Konety, Mohammad Saleem
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3538726?pdf=render

Internet

http://europepmc.org/articles/PMC3538726?pdf=render

Similar Items